Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to "streamline operations and reduce costs." 23andMe agreed to pay $30 million ...
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.
A stock can still have huge value even after a substantial rise in price. To find out if this is true for this FTSE 100 bank, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback